Nasdaq compliance removes a key overhang for a micro-cap stock that had been at risk of delisting since January 2026. Monitor the stock's ability to sustain price above $1.00 and watch for any fundamental catalysts (earnings, pipeline updates) that could provide further support. The flat to declining historical performance of prior events suggests limited sustained upside from this administrative fix alone.
Price Chart
Executive Summary
Autonomix Medical announced it received Nasdaq confirmation that it has regained compliance with the $1.00 minimum bid price rule, closing a deficiency notice from January 2026. The company's stock closed at or above $1.00 for ten consecutive business days ended July 8, 2026. This removes the immediate delisting risk for its Nasdaq listing.
Key Facts
- Regained compliance with Nasdaq's $1.00 minimum bid price rule per Listing Rule 5550(a)(2)
- Closing bid price was at or above $1.00 for 10 consecutive business days from June 24, 2026 through July 8, 2026
- Nasdaq notified the company on July 9, 2026 that the matter is closed
- Prior deficiency letter was received on January 14, 2026
- Market cap is approximately $4M
Financial Impact
Removal of delisting risk for a $4M market cap company — avoiding potential loss of Nasdaq listing and associated liquidity impact
Risk Factors
- Stock remains micro-cap ($4M market cap) with low liquidity — price volatility could again trigger bid price deficiency
- No financial or operating improvements disclosed — compliance alone does not address underlying business fundamentals
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-023248 |
| Document: 0001437749-26-023248-index-headers.html | 0001437749-26-023248 |
| Document: 0001437749-26-023248-index.html | 0001437749-26-023248 |
| Document: 0001437749-26-023248.txt | 0001437749-26-023248 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 3 | $3.01 | awaiting T+20 | — | $2.10 (−30.15%) |
Oct 2, 2026 25d ago | Press Release | $3.78 | awaiting T+20 | — | $2.10 (−44.38%) |
Sep 16, 2026 5w ago | 8-K | $4.12 $3.01 | ▼ −26.94% | ▼ −30.12% | $2.10 (−48.97%) |
Sep 16, 2026 5w ago | EFFECT | $4.12 $3.01 | ▲ +26.94% | ▲ +30.12% | $2.10 (+48.97%) |
Sep 11, 2026 6w ago | 424B5 | $4.33 $3.10 | ▲ +28.41% | ▲ +30.67% | $2.10 (+51.44%) |
Sep 4, 2026 7w ago | S-3 | $4.58 $3.47 | ▲ +24.24% | ▲ +25.95% | $2.10 (+54.09%) |
Aug 26, 2026 8w ago | 8-K | $5.63 $4.07 | ▼ −27.71% | ▼ −27.20% | $2.10 (−62.65%) |
Aug 5, 2026 11w ago | EFFECT | $12.10 $4.50 | ▼ −62.81% | ▼ −62.21% | $2.10 (−82.62%) |
Jul 28, 2026 13w ago | 8-K | $2.75 $7.19 | ▲ +161.45% | ▲ +158.07% | $2.10 (−23.54%) |
Jul 15, 2026 14w ago | 8-K | $4.92 $6.86 | ▼ −39.43% | ▼ −35.81% | $2.10 (+57.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers